
Aurora urges shareholders to reject Curaleaf's undervalued hostile bid and maintain their shares.
Aurora Cannabis has responded to Curaleaf's attempt to halt its at-the-market (ATM) program, calling Curaleaf's hostile bid undervalued and financially risky due to Curaleaf's heavy debt load. Aurora emphasizes that its ATM program, established befor...


